Boshi Wang Selected Research

Tumor Suppressor Proteins (Proteins, Tumor Suppressor)

1/2018

Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boshi Wang Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 01/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 01/2011
3	Carcinogenesis 01/2021 - 09/2013
3	Neoplasm Metastasis (Metastasis) 03/2019 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 09/2013
2	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 12/2014
2	Inflammation (Inflammations) 10/2018 - 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2020
1	Xerostomia 10/2020
1	Adenocarcinoma 08/2020
1	Adenocarcinoma of Lung 08/2020
1	Carotid Artery Injuries 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Hypertrophy 01/2019
1	Peritonitis 10/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Immune System Diseases (Immune Disorders) 01/2018
1	Fatigue 01/2017
1	Hematologic Diseases (Blood Diseases) 12/2016
1	Liver Neoplasms (Liver Cancer) 10/2015
1	Glioblastoma (Glioblastoma Multiforme) 12/2014
1	Colorectal Neoplasms (Colorectal Cancer) 12/2014
1	Leukemia 12/2013
1	Adenoma (Adenomas) 09/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2013
1	Ischemia 01/2013
1	Neuroinflammatory Diseases 01/2013
1	Infarction (Infarctions) 01/2013
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2013
1	Brain Edema (Cerebral Edema) 01/2013

Drug/Important Bio-Agent (IBA)

5	Deubiquitinating EnzymesIBA 11/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2011
2	Cisplatin (Platino)FDA LinkGeneric 08/2020 - 02/2013
2	LipopolysaccharidesIBA 10/2018 - 01/2013
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 12/2014
2	1- (2,4- dichlorobenzyl)indazole- 3- carbohydrazide (adjudin)IBA 02/2013 - 01/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	PlatinumIBA 08/2020
1	Indicators and Reagents (Reagents)IBA 08/2020
1	Caveolin 1IBA 03/2019
1	AndrogensIBA 01/2019
1	Pimozide (Orap)FDA Link 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	erucylphosphocholineIBA 01/2019
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	Evans Blue (Blue, Evans)FDA Link 01/2019
1	aluminum sulfate (alum)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	AcidsIBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2018
1	Factor XIII (Coagulation Factor XIII)IBA 01/2018
1	hepatitis B virus X proteinIBA 01/2016
1	Forkhead Box Protein M1IBA 10/2015
1	SurvivinIBA 10/2015
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 12/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013
1	Transforming Growth Factor-beta Type II ReceptorIBA 09/2013
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	CytokinesIBA 09/2013
1	LigandsIBA 09/2013
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 09/2013
1	CC ChemokinesIBA 09/2013
1	Cyclin D1IBA 09/2013
1	Adenosine Triphosphate (ATP)IBA 02/2013
1	Male Contraceptive Agents (Male Contraceptives)IBA 02/2013
1	Pharmaceutical PreparationsIBA 02/2013

Therapy/Procedure

7	Therapeutics 01/2022 - 02/2013
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2017
2	Hematopoietic Stem Cell Transplantation 12/2016 - 12/2013
1	Radiotherapy 10/2020
1	Transplantation 12/2013